Coexisting <i>BRAF</i>-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared <i>JAK2</i> Mutation

<div>(a) Tumor localized to the cheek of the patient. (b) Painless, nonitching maculopapular rash on the patient’s truncus. (c) Normalization of the skin after BRAF-inhibitor treatment.</div>

Case Reports in Hematology

fig1

Figure 1

Figure 1: Coexisting <i>BRAF</i>-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared <i>JAK2</i> Mutation 

Case Reports in Hematology

Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation

Figure 1